Among nearly 2,000 abdominal CT scans originally considered normal, an AI radiomics model identified 73% of prediagnostic pancreatic cancers, with a median lead time of about 16 months. Validation included images from multiple institutions and protocols. This analysis used scans taken before diagnosis; clinical benefit and false positives in practice still need prospective evaluation.
Technology: REDMOD (Radiomics-based Early Detection Model)
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: retrospective or benchmark
- Tested: REDMOD was trained on 969 patients from a multi-institutional cohort and tested on an independent set of 493 patients (63 pre-diagnostic), with external specificity checks on further datasets and a comparison with radiologists; AUC 0.82 and 73.0% sensitivity, versus 38.9% for radiologists.
- Still unknown: The article states that prospective validation in high-risk cohorts is the necessary next step; no explicit limitations section.
- AI role: A fully automated radiomics framework with AI segmentation and an ensemble classifier on a 40-feature signature from standard-of-care CT scans.
Evidence sources: https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-ai-detects-pancreatic-cancer-up-to-3-years-before-diagnosis-in-landmark-validation-study/ · https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI:10.1136/gutjnl-2025-337266&resultType=core&format=json
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: press release. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Editorial assessment: Impact 4/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.
An attention-based AI model extracting breathing from radio waves during sleep detected Parkinson's disease with an AUC of 0.90 on held-out data and 0.85 on external sets, across 7,671 individuals. Its severity estimates correlated with MDS-UPDRS scores (R = 0.94), and it worked for at-home assessment. Caveat: largely retrospective data and no prospective diagnostic trial reported.
Technology: Attention-based deep learning on contactless radio-wave breathing signals
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: retrospective or benchmark
- Tested: Parkinson's detection was tested on held-out data (AUC 0.90) and external test sets (AUC 0.85) across 7,671 individuals, and severity estimates were compared with MDS-UPDRS scores (R = 0.94).
- Still unknown: The authors describe the findings as initial evidence that the model may be useful for risk assessment before clinical diagnosis.
- AI role: Attention-based AI model extracting breathing from radio waves during sleep to detect and grade Parkinson's disease.
Evidence sources: https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI:10.1038/s41591-022-01932-x&resultType=core&format=json
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 321 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 4/5 · Validation 2/5 · Novelty 5/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.
A randomized study across 120 primary-care groups at 45 sites evaluated neural-network alerts on electrocardiograms from 22,641 adults. The intervention produced five additional diagnoses of low ejection fraction per thousand patients, without a global increase in echocardiography use. The result concerns identification of dysfunction, not improved clinical outcomes.
Technology: Convolutional neural network for electrocardiograms
Publication: Peer-reviewed paper · Test context: prospective or independent check. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: prospective or independent check
- Tested: A cluster-randomised trial across 120 primary-care teams (22,641 adults) compared AI-ECG alerts with usual care on new low-EF diagnoses within 90 days.
- Still unknown: Not reported in the abstract read; the trial measured diagnosis rather than clinical outcomes.
- AI role: Neural network analysed electrocardiograms and alerted clinicians to possible low ejection fraction.
Evidence sources: https://newsnetwork.mayoclinic.org/discussion/trial-demonstrates-early-ai-guided-detection-of-heart-disease-in-routine-practice/ · https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI%3A10.1038/s41591-021-01335-4&resultType=core&format=json
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: press release. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 467 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 4/5 · Validation 4/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.